安罗替尼联合伊立替康二线治疗小细胞肺癌的临床疗效及安全性#br#
吕艺华, 赵子龙, 黄革红, 巴雅尔, 杜伟, 高辉, 张美云
The clinical efficacy and safety of anlotinib combined with irinotecan as the second-line therapy in patients with small cell lung cancer
LYU Yi-hua, ZHAO Zi-long, HUANG Ge-hong, BA Ya-er, DU Wei, GAO Hui, ZHANG Mei-yun
天津医药
.
2021, (4): 436
-440
.
DOI: 10.11958/20202963
